Asia Pacific Spine Biologics Market, published by Market Data Forecast, this market is projected to be growing at a CAGR of 4.9%, to reach USD 525 million by 2022.
PR-Inside.com: 2017-12-07 12:37:01
Spine Biologics are the techniques which are used in spine fusion surgeries for treating spinal issues like tumours, trauma, spinal cord injuries and degenerative disc disorder by triggering the growth of bone formation during inflammation, repair, and restructure stages. Hence, a rise in the amount of spinal fusion surgeries has increased the spread of biologics in the orthopaedic industry.
Get a comprehensive overview of the Asia Pacific Spine Biologics Market: www.marketdataforecast.com/market-reports/asia-pacific-spine-bio ..
Asia Pacific Spine Biologics Market: Drivers & Restraints
Asia Pacific Spine Biologics market has shown huge growth owing to the quickly developing technology and the high demand for reliable and minimal surgical methods that increase the convenience of both patient and doctor. A growth in instances of disorders because of aging populace, rising government support, is also posing as the driving force in the market. The most problematic restraint market faces is the healthcare expenditure for these methods and the substitutes competition. There is an absence of enough skilled experts and also the dissatisfactory reimbursement cases.
Get accurate market forecast and analysis on the Asia Pacific Spine Biologics Market. Request a sample to stay up-to-date on the main trends affecting this market: www.marketdataforecast.com/market-reports/asia-pacific-spine-bio ..
Asia Pacific Spine Biologics Market: Segmentation
By Surgery Type
• Anterior Cervical Discectomy and Fusion
• Posterior Lumbar Interbody Fusion
• Transforaminal Lumbar Interbody Fusion
• Anterior Lumbar Interbody Fusion
• Lateral Lumbar Interbody Fusion
By Product Type
• Bone Graft
• Bone graft substitutes
o Synthetic bone grafts
o Demineralized bone matrix
o Bone Morphogenetic proteins
• Platelet rich plasma
• Bone marrow aspitaye therapy
• North America
o United States
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at www.marketdataforecast.com/market-reports/asia-pacific-spine-bio ..
Asia Pacific Spine Biologics Market: Overview
The Asia Pacific Spine Biologics market was valued at 414 million as of 2017 and the bone grafts substitutes category held the major share of this market.
Geographically, this region includes India, China, Australia, Japan, and South Korea. Asia Pacific has the highest potential CAGR sue to bettering healthcare sector and increased spending abilities of the people.
Asia Pacific Spine Biologics Market: Key Players
The Asia Pacific Spine Biologics market is filled with many players like Alphatec Holdings, Inc., Zimmer Biomet Holdings, Inc., Depuy Synthes (Johnson & Johnson), Orthofix International N.V., SeaSpine, Exactech, Inc., RTI Surgical, Inc., Globus Medical, Inc., Medtronic plc, and NuVasive, Inc.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind speciality with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
Market Data Forecast
531/MIG-II, Rd Number 1, Kukatpally Housing Board Colony, Kukatpally, Hyderabad, Telangana
# 539 Words